1-4 of 4
Mani Mohindru
Close
Sort by
Journal Articles

Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitors

Tony A. Navas, Mani Mohindru, Myka Estes, Jing Ying Ma, Lubomir Sokol, Perry Pahanish, Simrit Parmar, Edwin Haghnazari, Li Zhou, Robert Collins, Irene Kerr, Aaron N. Nguyen, Yin Xu, Leonidas C. Platanias, Alan A. List, Linda S. Higgins, Amit Verma
Journal: Blood
Blood (2006) 108 (13): 4170–4177.
https://doi.org/10.1182/blood-2006-05-023093
Published: 2006
Journal Articles

SD-208, a Novel Transforming Growth Factor Beta Receptor I Kinase Inhibitor, Can Stimulate Hematopoiesis in Myelodysplastic Syndrome Progenitors.

Amit Verma, Tony A. Navas, Jing Ying, Ma, Aaron N. Nguyen, Perry Pahanish, Mahesh Seetharam, Irene Kerr, Robert Collins, Mimi Kim, Mani Mohindru, Linda S. Higgins
Journal: Blood
Blood (2005) 106 (11): 3448.
https://doi.org/10.1182/blood.V106.11.3448.3448
Published: 2005
Journal Articles

Novel P38 MAP Kinase Inhibitor and Anti-P38 RNA Interference as Potential Therapeutic Approaches in Myelodysplastic Syndromes.

Mani Mohindru, Perry Pahanish, Efstratios Katsoulidis, Robert Collins, Thomas Rogers, Tony Navas, Linda Higgins, Leonidas Platanias, Amit Verma
Journal: Blood
Blood (2004) 104 (11): 470.
https://doi.org/10.1182/blood.V104.11.470.470
Published: 2004
Journal Articles

Myelosuppresive Effects of Interferon [slpha] and Transforming Growth Factor β Can Be Reversed by Novel p38 MAPK Inhibitor SD-282 through Inhibition of Cell Cycle Arrest.

Mani Mohindru, Perry Pahanish, Robert Collins, Tony Navas, Linda Higgins, Amit Verma
Journal: Blood
Blood (2004) 104 (11): 4229.
https://doi.org/10.1182/blood.V104.11.4229.4229
Published: 2004